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Abstract
Aim: To synthesise quantitative evidence on factors that impact hospital readmission
rates following ACS with comorbidities.
Design: Systematic review and narrative synthesis.
Data sources: A search of eight electronic databases, including Embase, Medline,
PsycINFO, Web of Science, CINAHL, Cochrane Library, Scopus and the Joanna Briggs
Institute (JBI).
Review methods: The search strategy included keywords and MeSH terms to identify
English language studies published between 2001 and 2020. The quality of included
studies was assessed by two independent reviewers, using Joanna Briggs Institute
(JBI) critical appraisal tools.
Results: Twenty-four articles were included in the review. All cause 30-day readmission rate was most frequently reported and ranged from 4.2% to 81%. Reported factors
that were associated with readmission varied across studies from socio-demographic,
behavioural factors, comorbidity factors and cardiac factors. Findings from some of
the studies were limited by data source, study designs and small sample size.
Conclusion: Strategies that integrate comprehensive discharge planning and individualised care planning to enhance behavioural support are related to a reduction in readmission rates. It is recommended that nurses are supported to influence discharge
planning and lead the development of nurse-led interventions to ensure discharge
planning is both coordinated and person-centred.
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I NTRO D U C TI O N

2018). According to the World Health Organization, ACS is associated with 126 deaths per 100,000 people on a global scale (World

Acute coronary syndrome (ACS) including unstable angina (UA) and

Health Organization, 2018). In Australia, approximately 7300 peo-

myocardial infarction (MI) with or without ST-segment elevation re-

ple died due to MI in 2018, which is equivalent to 20 deaths per

sults in significant morbidity and mortality and is associated with im-

day (Australian Institute of Health & Welfare, 2020). ACS not only

paired quality of life (Reed et al., 2017; World Health Organization,

results in sudden or premature death but also in increased costs
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to the health care system (Hess et al., 2016; Litovchik et al., 2019;

(File S1) (Preferred Reporting Items for Systematic Reviews and

McManus et al., 2016). People with ACS are at high risk for read-

Meta-Analyses) statement reporting (Moher et al., 2010) and was

mission and the rates of readmission following ACS are increasing

registered with PROSPERO (*registration number will be inserted

(Belitardo & Ayoub, 2015). A recent study in Brazil reported 42.6%

here post-review).

of people who experienced ACS were readmitted between 30 and
180 days post-
discharge (Oliveira et al., 2019). Similarly, the US
study of 3536 people post-acute MI, reported a 24.5% readmission

2.1.1 | Search methods

rate within one year (Dreyer et al., 2015). A study in Australia and
New Zealand indicated that 25% of patients were readmitted or

Gaps in the literature were identified through an initial scoping

died within 30 days following an acute MI (Labrosciano et al., 2017).

search of Medical Literature Analysis and Retrieval System Online

However, a Canadian study of 3411 people who experienced ACS

(MEDLINE) and Google Scholar. Keywords related to samples with

reported the highest readmission rate at 61.7% within one year

acute coronary syndrome diagnosis (‘acute coronary syndrome’,

following discharge (Southern et al., 2014). Readmission to hospi-

‘ACS’, ‘cardiovascular disease’) and terms related to 30-day readmis-

tal is influenced by a number of factors indicating the occurrence

sion rates (‘readmission*’, ‘rehospitalization*’, ‘repeat* admission*’)

of complications after discharge, which can impact on disease se-

were used to identify further key terms. Once the full search strat-

verity (Oliveira et al., 2019), and this reinforces the importance of

egy was established, concepts were combined with Boolean opera-

identifying factors such as the presence of comorbidities, clinical

tors ‘AND’ and ‘OR’ (Appendix 1). Studies were identified through a

condition and patients’ individual features both during and after

systematic search of eight electronic databases (Embase, Medline,

hospitalisation to reduce complications that may affect readmission

PsycINFO, Cumulative Index to Nursing and Allied Health Literature

outcomes (Oliveira et al., 2019; Walraven et al., 2012). Readmission

(CINAHL), Web of Science, Cochrane Library, Scopus and the Joanna

to hospital among ACS patients is related to increased medical costs

Briggs Institute (JBI) in January 2020. Systematic review reference

reduced quality of life and poorer health outcomes (Budiman et al.,

lists were hand searched for additional eligible literature.

2016). Identifying factors that affect readmission has the potential
to improve quality of life, discharge follow-up, care coordination
and reduce avoidable healthcare expenditure (Dreyer et al., 2015;

2.1.2 | Study selection and inclusion criteria

Oliveira et al., 2019; Southern et al., 2014). Readmission is a multifactorial phenomenon and influenced by underlying comorbidities,

All search results were imported into EndNote X9 with the aim of

patient factors, healthcare system and organisational factors (Rocca

removing duplicates records. Two independent reviewers screened

et al., 2020). To date, a study has assessed and evaluated readmis-

the titles and abstracts of the full-text articles against the inclusion

sion related to patients with MI (Labrosciano et al., 2017); however,

criteria set out in the protocol. All peer-reviewed experimental and

readmission rates post-ACS are not clear (Kwok et al., 2017; Nguyen

observational study designs were considered for inclusion. Only stud-

et al., 2018) and further evidence on factors influencing readmission

ies classified as primary research, published in English since 2001 in a

associated with ACS is minimal (Oliveira et al., 2019). Moreover, prior

peer-reviewed journal were considered. This time frame was consid-

research on readmission rates following an ACS plus comorbidity

ered as preliminary searches indicated an upsurge in the discourse on

has not been systematically reviewed and factors affecting hospital

treatment adherence potentially influencing 30-day readmission rates.

readmission are currently lacking. Therefore, improved knowledge

This review considered populations diagnosed with acute coronary

of factors affecting readmissions is important to develop targeted

syndrome or ischaemic-related cardiovascular conditions and identi-

strategies to reduce readmissions rates. The aim of this review was

fied comorbidity on initial admission with a subsequent presentation

to identify factors that are associated with hospital readmission

to hospital for treatment within 30 days. The diagnosis of ACS includes

within 30 days following ACS.

the suspicion or confirmation of acute myocardial ischaemia or infarction. Non-ST-elevation myocardial infarction (NSTEMI), ST-elevation

2
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MI (STEMI) and unstable angina are the three traditional classifications
of ACS, which were considered for this review. This review focused on
adults aged 18 years and over. Studies were excluded from the review

To synthesise quantitative evidence on factors that impact hospital

if they included participants under 18 years old, had non-ischaemic

readmission rates following ACS with comorbidities.

heart failure or had received open heart surgery. Animal studies and
grey literature were excluded. This review assessed the readmission

2.1 | Methods

rate of patients occurring within 30 days of receiving care for an acute
coronary syndrome episode in an acute care setting. The outcomes of
interest for this review were the factors that influenced 30-day read-

A systematic review was conducted in accordance with the Joanna

mission in patients that had an initial hospitalisation for acute coronary

Briggs Institute (JBI) methodology for systematic reviews of quanti-

syndrome or ischaemic-related cardiovascular condition. These fac-

tative evidence (Moher et al., 2010). This review follows the PRISMA

tors could include, but were not limited to, education, treatment plan

|
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implementation and adherence, communication, quality of life, general

9132 papers remained. These titles were screened by two inde-

health outcomes, physical well-
being, emotional wellbeing, comor-

pendent reviewers. A total of 818 abstracts were reviewed for suit-

bidities, stress or psychosocial well-being as assessed through data re-

ability. Full texts of 321 articles were assessed for eligibility by two

trieved from medical records/database review, patient questionnaires

independent reviewers, with 297 excluded for not meeting inclusion

or patient interviews.

criteria. Reasons for exclusion included the primary diagnosis on
admission (n = 104), patients who underwent a coronary artery by-

2.1.3 | Quality appraisal and data extraction

pass grafting procedure during the admission (n = 38), readmission
outside of the 30-day period (n = 62), comorbidities not reported
(n = 80), grey literature (n = 7), reviews (n = 4), non-adult sample

Methodological quality and risk of bias within included studies were

(n = 1) and paper not published in English (n = 1). An overall GRADE

independently appraised by two reviewers. JBI Critical appraisal tools

quality rating of low was assigned to findings in relation to factors

were utilised to assess the quality of studies (Manual, 2014). Any

that influence 30 days readmission rates, mostly due to the nature of

disagreements that arose between reviewers were discussed and re-

the study design being observational.

solved by all authors. A Grading of Recommendations Assessment,
Development and Evaluation (GRADE) was completed to evaluate
the certainty of the evidence by assessing consistency of results be-

3.2 | Methodological quality of included studies

tween studies, directness and precision of findings, study limitations
and probability of publication bias. The overall quality of evidence was

A summary of the quality assessment of the included studies is pre-

categorised as high, moderate, low or very low. Two researchers com-

sented in Appendix 3. The 24 included studies were critically ap-

pleted the GRADE assessments independently. Any discrepancies be-

praised by two independent reviewers using the JBI checklist. Of

tween reviewers were discussed by the research team.

the 22 cohort studies (maximum quality score 11), 15 studies were

Data were extracted from included studies using the JBI stan-

assigned a score of 9 (Borzecki et al., 2016; Cheung et al., 2018;

dardised data extraction tools by study design (Piper, 2019). Data

Dharmarajan et al., 2013; Dodson et al., 2019; Hess et al., 2016;

extracted included country, study design, type of patient (referring

Khera et al., 2017; Li et al., 2019; Litovchik et al., 2019; Mahmoud

to reason for initial admission), sample size, sample demographics

& Elgendy, 2018; McHugh & Ma, 2013; McManus et al., 2016;

(age and sex), intervention details, data source or measurement and

Meadows et al., 2012; Przybysz-Zdunek et al., 2012; Southern et al.,

comorbidity or outcome of interest (referring to the factors that

2014; Zabawa et al., 2018), five studies scored 11 (Dreyer et al.,

could impact on readmission rates), as well as key findings. Queries

2015; Kociol et al., 2012; Rodriguez et al., 2011; Tripathi et al., 2017,

on data were followed up with the corresponding authors of each

2019) and the remaining studies scored 10 (Nuti et al., 2016) and 6

study. One author was contacted to gain clarification on the data, as

(Atti et al., 2019), respectively. The RCT studies scored 10 (maximum

conflicting sample characteristics were reported; however, no return

quality score 13) (Cajanding, 2017). The quasi-experimental study

correspondence was received.

scored 8/9 (Gasbarro et al., 2015).

2.1.4 | Data synthesis

3.3 | Characteristics of included studies

Key findings have been narratively synthesised to demonstrate

Appendix 4 presents an overview of the study characteristics. All in-

key barriers and facilitators for 30 days readmission rates. Meta-

cluded studies (n = 24) were published in English between 2001 and

analysis was not completed due to heterogeneity in data collection

2020. This review included five prospective cohort studies (Dodson

time points, source of data, study design and collection methods.

et al., 2019; Hess et al., 2016; Li et al., 2019; Litovchik et al., 2019;

Therefore, a narrative synthesis was conducted according to the

McManus et al., 2016), 17 retrospective cohort studies (Atti et al.,

Synthesis Without Meta-analysis (SWiM) guidelines (Campbell et al.,

2019; Borzecki et al., 2016; Cheung et al., 2018; Dharmarajan et al.,

2020). The review was approved by the Human Research Ethics

2013; Dreyer et al., 2015; Khera et al., 2017; Kociol et al., 2012;

Committee of University (2021-02514).

Mahmoud & Elgendy, 2018; McHugh & Ma, 2013; Meadows et al.,
2012; Nuti et al., 2016; Przybysz-Zdunek et al., 2012; Rodriguez

3
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3.1 | Study inclusion

et al., 2011; Southern et al., 2014; Tripathi et al., 2017, 2019; Zabawa
et al., 2018), one RCT (Cajanding, 2017) and one quasi-experimental
(Gasbarro et al., 2015). The sample size of studies ranged from 50
(Gasbarro et al., 2015) to 212,171 (Khera et al., 2017). The majority of
studies were conducted in the USA (Atti et al., 2019; Borzecki et al.,

A PRISMA flow diagram outlining the selection of eligible studies is

2016; Cheung et al., 2018; Dharmarajan et al., 2013; Dodson et al.,

presented in Appendix 2. Initially, 13515 articles were retrieved from

2019; Dreyer et al., 2015; Gasbarro et al., 2015; Hess et al., 2016;

databases and manual searching. After the removal of duplicates,

Khera et al., 2017; Kociol et al., 2012; Mahmoud & Elgendy, 2018;

4
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McHugh & Ma, 2013; McManus et al., 2016; Meadows et al., 2012;

Przybysz-Zdunek et al., 2012; Rodriguez et al., 2011; Tripathi et al.,

Nuti et al., 2016; Tripathi et al., 2017, 2019), two studies in Canada

2017; Zabawa et al., 2018).

(Kociol et al., 2012; Southern et al., 2014) and one in France (Zabawa
et al., 2018), Spain (Rodriguez et al., 2011), Poland (Przybysz-Zdunek
et al., 2012), Israel (Litovchik et al., 2019), Philippines (Cajanding,

3.4.3 | Factors affecting hospital readmission

2017) and China (Li et al., 2019). Nine studies were conducted in a
hospital setting (Cajanding, 2017; Dodson et al., 2019; Gasbarro et al.,

Studies focused on identifying factors that affected readmission

2015; Hess et al., 2016; Kociol et al., 2012; Li et al., 2019; Litovchik

within 30 days among ACS patients and across the review studies, a

et al., 2019; McManus et al., 2016; Przybysz-Zdunek et al., 2012),

variety factors related to higher hospital readmission rates within a

seven studies extracted data from hospital databases, including re-

30-day period. The factors have been presented in four categories:

admission, admission and discharge data (Atti et al., 2019; Borzecki

socio-demographic factors, behavioural factors, comorbidities and

et al., 2016; Cheung et al., 2018; McHugh & Ma, 2013; Meadows

cardiac disease.

et al., 2012; Southern et al., 2014; Zabawa et al., 2018), five studies used national readmission databases (Dreyer et al., 2015; Khera
et al., 2017; Mahmoud & Elgendy, 2018; Tripathi et al., 2017, 2019)

3.4.4 | Socio-demographic factors

and three studies used Medicare service claims data (Dharmarajan
et al., 2013; Nuti et al., 2016; Rodriguez et al., 2011).

Eight studies demonstrated a link between female gender and
higher likelihood of readmission within 30 days (Atti et al., 2019;

3.4 | Review findings

Dreyer et al., 2015; Hess et al., 2016; Khera et al., 2017; Mahmoud
& Elgendy, 2018; Przybysz-Zdunek et al., 2012; Tripathi et al., 2017,
2019). However, one study reported that gender was not signifi-

3.4.1 | Timing of readmission

cantly associated with readmission within 30 days (Li et al., 2019).
Age was strongly associated with readmission within 30 days,

There were notable differences in the weighted median and

with increased age associated with increased rates of readmission

mean time to readmission across the studies. Thirteen studies did

(Dharmarajan et al., 2013; Dodson et al., 2019; Hess et al., 2016;

not report either median or mean time to readmission (Borzecki

Khera et al., 2017; McManus et al., 2016; Przybysz-Zdunek et al.,

et al., 2016; Cajanding, 2017; Gasbarro et al., 2015; Hess et al.,

2012; Tripathi et al., 2019). However, three studies (Dreyer et al.,

2016; Khera et al., 2017; Kociol et al., 2012; Litovchik et al., 2019;

2015; Khera et al., 2017; Southern et al., 2014) reported that older

McHugh & Ma, 2013; McManus et al., 2016; Meadows et al., 2012;

age was associated with a lower risk of readmission. One study (Li

Nuti et al., 2016; Przybysz-Zdunek et al., 2012; Rodriguez et al.,

et al., 2019) demonstrated that there was no association between

2011). Studies reported the median time to readmission of 2 days

age and readmission. Two studies suggested that lower household

(Dreyer et al., 2015), 5 days (Li et al., 2019), 9 days (Tripathi et al.,

income was associated with high readmission rates (Cheung et al.,

2019), 10 days (Cheung et al., 2018; Dharmarajan et al., 2013;

2018; Khera et al., 2017). Two studies (Li et al., 2019; Tripathi et al.,

Dodson et al., 2019; Tripathi et al., 2017) and 11 days (Atti et al.,

2017) did not report an association between household income and

2019; Mahmoud & Elgendy, 2018). One study reported the median

rates of readmission. The association between race and readmission

time from discharge to readmission of 0.8 months (Southern et al.,

was examined in two studies that reported non-white patients (Hess

2014).

et al., 2016) and Hispanic patients (Rodriguez et al., 2011) were more
likely to be readmitted within 30 days.

3.4.2 | Readmission rates

3.4.5 | Behavioural factors

The percentage of patients experiencing readmission within
30 days ranged from 4.2% (Litovchik et al., 2019) to 81% (Borzecki

Four studies (Cheung et al., 2018; Dodson et al., 2019; Hess et al.,

et al., 2016). Less than 10% readmission was reported in three

2016; Mahmoud & Elgendy, 2018) identified an association between

studies (6% (Li et al., 2019)-9% (McHugh & Ma, 2013)). Two stud-

smoking and readmission. Cigarette smoking was significantly as-

ies reported similar readmission rates at 34% (Cajanding, 2017;

sociated with a higher likelihood of readmission, irrespective of

Southern et al., 2014). A readmission rate of 11% was reported

whether the patient was a current smoker (Cheung et al., 2018;

in three studies (Gasbarro et al., 2015; Hess et al., 2016; Kociol

Mahmoud & Elgendy, 2018). One study indicated an association be-

et al., 2012). The remaining 13 studies ranged between 12% and

tween the status, current smoker and readmission within 30 days

25% (Atti et al., 2019; Cheung et al., 2018; Dharmarajan et al.,

(Dodson et al., 2019). However, another study identified that ciga-

2013; Dodson et al., 2019; Dreyer et al., 2015; Khera et al., 2017;

rette smoking was linked with lower rates of unplanned readmission

Mahmoud & Elgendy, 2018; McManus et al., 2016; Nuti et al., 2016;

within 30 days (Hess et al., 2016).

|
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3.4.6 | Comorbidity factors

4

All 24 studies reported the prevalence of comorbidities includ-

To the best of our knowledge, this is the first review to assess the

ing diabetes, hypertension, pulmonary disease, renal disease

prevalence of readmission within 30 days among people with ACS

and anaemia. These studies provided evidence of a relationship

and comorbidity. This review was based on 24 studies that met

between different comorbidities and readmission with 30 days.

the inclusion criteria. The findings suggest that hospital readmis-

Seven studies reported an association between the comorbid

sion within 30 days varied among persons who had experienced

diagnosis of diabetes and increased rates of readmission (Atti

ACS and many factors contributed to an increased risk of read-

et al., 2019; Hess et al., 2016; Kociol et al., 2012; Mahmoud &

mission. The most reported factors associated with an increased

Elgendy, 2018; Przybysz-
Zdunek et al., 2012; Southern et al.,

risk of readmission were gender, age, ethnicity, smoking status, re-

2014; Tripathi et al., 2019). Likewise, three studies (Hess et al.,

current ischaemic events, arrhythmia, heart failure, renal disease,

2016; Kociol et al., 2012; Przybysz-Zdunek et al., 2012) reported

anaemia, diabetes, hypertension and pulmonary complications. Of

patients with hypertension were more likely to be readmitted

interest, comorbidities were often reported as related to readmis-

within 30 days. Eight studies found that pulmonary disease or

sion, however, cardiac disease factors were most often reported

complications significantly predicted readmission within 30 days

as the principal diagnosis for hospital readmission. Further clarity

(Atti et al., 2019; Cheung et al., 2018; Dreyer et al., 2015; Kociol

on the reason for readmission, for example, recurrent MI, acute

et al., 2012; Mahmoud & Elgendy, 2018; Southern et al., 2014;

kidney injury, exacerbation of heart failure or pneumonia versus

Tripathi et al., 2017, 2019). Four studies reported that patients

the factors related to readmission, for example history of renal

who suffered from anaemia had a higher probability of readmis-

disease, existing lung disease and diabetes is needed within the

sion (Atti et al., 2019; Cheung et al., 2018; Mahmoud & Elgendy,

literature to make this distinction clearer.

|

DISCUSSION

2018; Tripathi et al., 2019). Another nine studies reported the re-

Hospital readmission in people with ACS is increasingly rec-

lationship between renal disease and readmission within 30 days

ognised as an important healthcare issue. Overall, readmission

(Atti et al., 2019; Cheung et al., 2018; Hess et al., 2016; Mahmoud

rates ranged from 4.2% in Israel (Litovchik et al., 2019) to 81%

& Elgendy, 2018; McManus et al., 2016; Przybysz-Zdunek et al.,

in the United States of America (Borzecki et al., 2016). Much of

2012; Southern et al., 2014; Tripathi et al., 2017, 2019; Zabawa

the variability in the readmission rate were related to two issues.

et al., 2018).

Firstly, the variability in sources of data, data collection time
points and study design. Secondly, no study reported the number of people readmitted against the number who survived. The

3.4.7 | Cardiac disease factors

findings reported do not account for variation across healthcare
systems and health across societies on readmission rates. The 30-

Of the 24 studies reviewed, five studies did not report cardiac fac-

day period post-discharge is a crucial interval when people are

tors as the principal diagnosis for hospital readmission (Borzecki

most vulnerable (Dharmarajan et al., 2013; Khera et al., 2020).

et al., 2016; Gasbarro et al., 2015; Khera et al., 2017; Nuti

Reducing readmission during this intense period of recovery and

et al., 2016; Zabawa et al., 2018). However, a recurrent ischaemic

adjustment requires hospital intervention that shares character-

event, including re-infarction and unstable angina, was consist-

istics of patient-centred care involving the interdisciplinary team

ently reported as the leading cause of readmission in 12 studies

and better discharge planning practices.

(Cajanding, 2017; Dharmarajan et al., 2013; Dreyer et al., 2015;

This review also indicates that readmission varied by gender.

Hess et al., 2016; Kociol et al., 2012; Li et al., 2019; Litovchik

Females had a higher likelihood of readmission within 30 days com-

et al., 2019; McManus et al., 2016; Przybysz-Zdunek et al., 2012;

pared to males. This may be because they have home/family roles,

Rodriguez et al., 2011; Tripathi et al., 2017, 2019). Heart failure

including providing care for family members, undertake more do-

was also a common cause of hospital readmission in four studies

mestic work and additional caregiving responsibilities.

(Atti et al., 2019; McHugh & Ma, 2013; Tripathi et al., 2017, 2019).

The influence of these factors could add to their vulnerabil-

In three studies, the principal diagnosis for hospital readmission

ity for readmission and can act as a potential explanation for the

among people with ACS included percutaneous coronary inter-

gender differences in readmission. This finding links with previous

vention (PCI) (Meadows et al., 2012; Przybysz-Zdunek et al., 2012;

research in which females had worse physical and mental health

Southern et al., 2014). A variety of cardiac conditions including

outcomes after MI (Cenko et al., 2018; Shih et al., 2019). Thirty

arrhythmia (Cheung et al., 2018; Dodson et al., 2019; Mahmoud

days post-index hospitalisation, females were more likely to be re-

& Elgendy, 2018; McHugh & Ma, 2013), followed by atrial fibril-

admitted than males (38.3% versus 29.6%; p < .001) (Wasfy et al.,

lation (Mahmoud & Elgendy, 2018; Przybysz-Zdunek et al., 2012)

2013). This disparity has been related to a number of potential

and congestive heart failure (Cheung et al., 2018; Dodson et al.,

factors including actions taken or omitted during the initial hos-

2019; Przybysz-Zdunek et al., 2012) were reported to be associ-

pital stay, a consequence of incomplete treatment or coordination

ated with readmission.

of post-discharge care (Kwok et al., 2018) and may include the

6
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roles and responsibilities of women in providing care for children

on living conditions and marital status was not reported. Further

and family that impacts on recovery and makes women more sus-

investigation is needed to examine if these factors play a role in re-

ceptible to readmission (Rose et al., 1996). Further studies need

admission rates, and why marital status. Fourthly, most of reviewed

to be conducted to determine why women are more likely to be

studies were retrospective and prospective designs, and limited RCT

readmitted than men (Dreyer et al., 2015). Our findings also sug-

and experimental studies have been conducted to demonstrate the

gested racial disparities in readmission rates. Hispanic and non-

cause and effect of relationships between factors. Lastly, studies

white groups have a higher risk of readmission, compared with

have used information from databases, administrative data and clini-

non-Hispanic and white patients in Spain and USA, respectively

cal data making it difficult to generalise some of the findings. Further

(Correa-d e-A raujo et al., 2006; Joynt et al., 2011). One study sug-

research is needed to examine readmission following medical index

gested that higher readmission rates among Hispanic patients may

admissions, and to develop and evaluate the effectiveness of nurse-

be related to lower quality care, for example Hispanics were less

led interventions to reduce readmission among this population. Such

likely to be offered an assessment of left ventricular function,

interventions need to be integrated with cardiology services to tar-

(Correa-d e-A raujo et al., 2006; Joynt et al., 2011). This finding is

get conditions with the highest rates of readmission in order to im-

echoed in a further study (Joynt et al., 2011) that highlighted dis-

prove patient's outcome and reduce preventable readmissions.

parities in readmission rates between black and white patients in
the USA and related to race itself as well as to the site where care
was provided.
Prominent non-cardiac factors that influenced readmission rates

6 | CO N C LU S I O N A N D I M PLI C ATI O N FO R
PR AC TI C E

were pulmonary causes or complications, hypertension, diabetes
and renal disease, followed by cardiac factors, including recurrent

This review identified comorbidities and cardiac factors that were

ischaemic event, PCI, arrhythmia and heart failure. Having the diag-

associated with readmission and there is clear and convincing evi-

nosis of ACS and the presence of comorbidities places people at high

dence that hospital readmission is prevalent in patients with ACS.

risk for hospital readmission (Condon & Mcdonnell, 2012; Gandjour

Recurrent ischaemic events, heart failure and arrythmias were the

et al., 2012). Reported comorbid conditions varied by studies, some

principal cardiac factors related to readmission. Meanwhile, com-

studies considered the number of chronic conditions or the Charlson

mon comorbidities such as kidney disease, hypertension, diabetes

comorbidity score to assess comorbidity. A similar study also indi-

and pulmonary complications were significant factors related to re-

cated that patients with acute myocardial infarction (AMI) and di-

admission. However, little evidence indicates the degree to which

abetes were twice as likely to be readmitted than those without

readmission may be preventable. Some factors such as smoking,

diabetes (Tavani et al., 2002). Those who experienced an AMI and

with diabetes, anaemia and hypertension are modifiable factors and

were diagnosed with renal disease are high risk of readmission within

can be influenced by nurses. Therefore, efforts among nurses to re-

30 days (Dunlay et al., 2012). Indeed, previous studies indicated that

duce readmission could include comprehensive discharge planning,

8% of people were readmitted within 30 days after PCI (Yost et al.,

individualised care planning, behavioural support and home visits.

2013). However, a recent review suggested that there is still ongo-

Interventions that address patient need, especially unmet needs

ing debate on whether PCI can decrease 30-day readmission rates

have the potential to improve health outcomes and reduce readmis-

(Wang et al., 2019). Studies indicated that 58% of recurrent coronary

sion rates. To effectively reduce hospital readmissions in individuals

readmissions were due to unstable angina (Yudi et al., 2019). This

with ACS, nurses can identify individuals at high risk for readmission

review summarised the factors that influenced readmission within

based on the risk factors highlighted in this review. Addressing the

30 days following ACS. It highlights the need for early follow-up with

issues related to disparities is challenging; however, the evidence

attention to the predictors of readmission, and interventions to re-

has highlighted differences in the investigations undertaken, care

duce readmissions within 30 days for this population.

provided and attention to discharge planning. The findings in this
review highlight the key areas related to readmission and those areas

5
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The strength of this review was the implementation of a thorough
search strategy across eight databases. The JBI manual provided a

that are modifiable to inform and shape the development of targeted
strategies to reduce readmission rates among people post-ACS.
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comprehensive guide to conducting this systematic review. However,
this review has limitations. First, due to heterogeneity among in-

• This review highlights that healthcare providers, particularly

cluded studies, a meta-analysis was not possible; therefore, a nar-

nurses need to provide comprehensive and individualised patient-

rative review of the existing evidence was provided. Secondly, the

centred interventions to reduce readmission by identifying fac-

inclusion of English only studies could result in relevant studies being

tors related to readmission and unmet patient needs.

missed. Thirdly, heterogeneity among sampling made some compari-

• Nurses play an important role in supporting patients and pro-

sons challenging. Apart from three studies, readmission rates based

viding continuity and individualisation of care. Adopting the

|
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recommended strategies may help nurses within the clinical
practice setting both pre-and post-hospital discharge to reduce
readmission.
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S E A R C H S T R AT EG Y
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OR ("repeat* admission*") OR "rehospitali#ation" OR ("re-admission"
OR "re-hospitalization") OR ("readmission rates in hospital*")) AND
("factor" OR "reason*" OR "influence*" OR "cause*") AND ((""acute
setting*"") OR "hospital*").

Medline: (Filtered for 2001–2020 and English)
((""cardiovascular disease"" OR (MH "Cardiovascular Diseases")) OR

Cochrane: (Filtered for 2001–2020)

(""coronary artery disease*"" OR (MH "Coronary Artery Disease")

("acute coronary syndrome" OR "myocardial infarct*" OR "cardio-

OR (MH "Coronary Disease")) OR (""coronary heart disease*"") OR

vascular disease" OR "coronary artery disease*" OR "coronary heart

((MH "Acute Coronary Syndrome") OR ""acute coronary syndrome"")

disease*" OR "unstable angina" OR "myocardial ischemia" OR "is-

OR ((MH "Myocardial Infarction") OR ""myocardial infarct*"")

chemic heart failure" OR " CVD" OR "CAD" OR "ACS" OR "MI" OR

OR ((MH "Angina, Unstable") OR ""unstable angina"") OR ((MH

"CHD" OR "heart attack" OR "cardiac arrest" OR "heart disease*")

"Myocardial Ischemia") OR ""myocardial ischemia"") OR (""ischemic

AND ("readmission rate*" OR "readmission rates within 30 days"

heart failure"" OR (MH "Heart Failure")) OR "CVD" OR "CAD" OR

OR "readmission*" OR "repeat* admission*" OR "rehospitali#ation"

"MI" OR "CHD" OR ((MH "Heart Arrest") OR ""cardiac arrest"") OR

OR "re-admission*" OR "readmission rate in hospital*") AND ("fac-

(""heart disease"") OR (""heart attack"") OR ((MH "Heart Diseases"))

tor*" OR "cause*" OR "reason*" OR "influence") AND ("hospital*" OR

OR "ACS") AND (((MH "Patient Readmission") OR ""readmission*"")

"acute setting*").

OR (""readmission rate*"") OR (""readmission rates within 30 days"")
OR ("repeat* admission*") OR "rehospitali#ation" OR ("re-admission"

WoS: (Filtered for 2001–2020 and English)

OR "re-hospitalization") OR ("readmission rates in hospital*")) AND

("acute coronary syndrome" OR "myocardial infarct*" OR "cardio-

("factor" OR "reason*" OR "influence*" OR "cause*") AND ((""acute

vascular disease" OR "coronary artery disease*" OR "coronary heart

setting*"") OR "hospital*").

disease*" OR "unstable angina" OR "myocardial ischemia" OR "ischemic heart failure" OR " CVD" OR "CAD" OR "ACS" OR "MI" OR

CINAHL: (Filtered for 2001–2020 and English)

"CHD" OR "heart attack" OR "cardiac arrest" OR "heart disease*")

((""cardiovascular disease"" OR (MH "Cardiovascular Diseases")) OR

AND ("readmission rate*" OR "readmission rates within 30 days"

(""coronary artery disease*"" OR (MH "Coronary Artery Disease")

OR "readmission*" OR "repeat* admission*" OR "rehospitali#ation"

OR (MH "Coronary Disease")) OR (""coronary heart disease*"") OR

OR "re-admission*" OR "readmission rate in hospital*") AND ("fac-

((MH "Acute Coronary Syndrome") OR ""acute coronary syndrome"")

tor*" OR "cause*" OR "reason*" OR "influence") AND ("hospital*" OR

OR ((MH "Myocardial Infarction") OR ""myocardial infarct*"")

"acute setting*").

OR ((MH "Angina, Unstable") OR ""unstable angina"") OR ((MH
"Myocardial Ischemia") OR ""myocardial ischemia"") OR (""ischemic

Embase

heart failure"" OR (MH "Heart Failure")) OR "CVD" OR "CAD" OR

(‘cardiovascular disease'/exp OR ‘acute coronary syndrome'/exp

"MI" OR "CHD" OR ((MH "Heart Arrest") OR ""cardiac arrest"") OR

OR ‘heart infarction'/exp OR ‘coronary artery disease'/exp OR ‘is-

(""heart disease"") OR (""heart attack"") OR ((MH "Heart Diseases"))

chemic heart disease'/exp OR ‘coronary heart disease’ OR ‘myocar-

OR "ACS") AND (((MH "Patient Readmission") OR ""readmission*"")

dial infarction’ OR ‘unstable angina pectoris'/exp OR ‘heart muscle

OR (""readmission rate*"") OR (""readmission rates within 30 days"")

ischemia'/exp OR ‘ischemic heart failure'/exp OR cvd OR cad OR acs

OR ("repeat* admission*") OR "rehospitali#ation" OR ("re-admission"

OR mi OR chd OR ‘heart attack’ OR ‘heart disease'/exp OR ‘heart

OR "re-hospitalization") OR ("readmission rates in hospital*")) AND

arrest'/exp) AND (‘hospital readmission'/exp OR ‘readmission rate’

("factor" OR "reason*" OR "influence*" OR "cause*") AND ((""acute

OR ‘readmission rate within 30 days’ OR readmission OR ‘repeated

setting*"") OR "hospital*").

admission’ OR rehospitalisation OR hospitalisation OR ‘re admission’ OR ‘re hospitalization’ OR ‘re hospitalization’ OR ‘readmission

PsycINFO: (Filtered for 2001–2020 and English)

rate in hospital’) AND (factors OR influence OR cause OR reason)

((""cardiovascular Disease"" OR (MH "Cardiovascular Diseases")) OR

AND (‘hospital'/exp OR ‘acute setting’) AND (2001:py OR 2002:py

(""coronary artery disease*"" OR (MH "Coronary Artery Disease")

OR 2003:py OR 2004:py OR 2005:py OR 2006:py OR 2007:py

OR (MH "Coronary Disease")) OR (""coronary heart disease*"") OR

OR 2008:py OR 2009:py OR 2010:py OR 2011:py OR 2012:py

((MH "Acute Coronary Syndrome") OR ""acute coronary syndrome"")

OR 2013:py OR 2014:py OR 2015:py OR 2016:py OR 2017:py OR

OR ((MH "Myocardial Infarction") OR ""myocardial infarct*"")

2018:py OR 2019:py OR 2020:py) AND [humans]/lim AND [english]/

OR ((MH "Angina, Unstable") OR ""unstable angina"") OR ((MH

lim.

"Myocardial Ischemia") OR ""myocardial ischemia"") OR (""ischemic
heart failure"" OR (MH "Heart Failure")) OR "CVD" OR "CAD" OR

Scopus

"MI" OR "CHD" OR ((MH "Heart Arrest") OR ""cardiac arrest"") OR

((TITLE-ABS-KEY ("readmission rates in hospital")) OR (TITLE-ABS-

(""heart disease"") OR (""heart attack"") OR ((MH "Heart Diseases"))

KEY ("re-
admission*")) OR (TITLE-
ABS-
KEY ("rehospitalization*"))

OR "ACS") AND (((MH "Patient Readmission") OR ""readmission*"")

OR (TITLE-
ABS-
KEY ("repeat* admission*")) OR (TITLE-
ABS-

OR (""readmission rate*"") OR (""readmission rates within 30 days"")

KEY ("readmission rate*")) OR (TITLE-
ABS-
KEY (readmission*))
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OR (TITLE-
ABS-
KEY ("readmission rates within 30 days"))) AND

(PUBYEAR, 2016) OR LIMIT-
TO (PUBYEAR, 2015) OR LIMIT-
TO

((TITLE-ABS-KEY ("influence*")) OR (TITLE-ABS-KEY ("reason*"))

(PUBYEAR, 2014) OR LIMIT-
TO (PUBYEAR, 2013) OR LIMIT-
TO

OR (TITLE-ABS-KEY (cause*)) OR (TITLE-ABS-KEY (factor*))) AND

(PUBYEAR, 2012) OR LIMIT-
TO (PUBYEAR, 2011) OR LIMIT-
TO

((TITLE-
ABS-
KEY (hospital*)) OR (TITLE-
ABS-
KEY ("acute set-

(PUBYEAR, 2010) OR LIMIT-TO (PUBYEAR, 2009) OR LIMIT-TO

ting*"))) AND ((TITLE-
ABS-
KEY ("cardiovascular disease")) OR

(PUBYEAR, 2008) OR LIMIT-TO (PUBYEAR, 2007) OR LIMIT-TO

(TITLE-ABS-KEY ("coronary heart disease*")) OR (TITLE-ABS-KEY

(PUBYEAR, 2006) OR LIMIT-TO (PUBYEAR, 2005) OR LIMIT-TO

("coronary artery disease*")) OR (TITLE-
ABS-
KEY ("acute coro-

(PUBYEAR, 2004) OR LIMIT-TO (PUBYEAR, 2003) OR LIMIT-TO

nary syndrome")) OR (TITLE-ABS-KEY ("myocardial infarct*")) OR

(PUBYEAR, 2002) OR LIMIT-TO (PUBYEAR, 2001)) AND (LIMIT-TO

(TITLE-
ABS-
KEY ("unstable angina")) OR (TITLE-
ABS-
KEY ("myo-

(LANGUAGE, "English")).

cardial ischemia")) OR (TITLE-ABS-KEY ("ischemic heart failure"))
OR (TITLE-ABS-KEY (cvd)) OR (TITLE-ABS-KEY (cad)) OR (TITLE-

JBI

ABS-KEY (acs)) OR (TITLE-ABS-KEY (mi)) OR (TITLE-ABS-KEY (chd))

(“acute coronary syndrome” OR “heart disease” OR “myocardial

OR (TITLE-ABS-KEY ("heart disease*")) OR (TITLE-ABS-KEY ("heart

infarction”) AND (“readmission” OR “rehospitalization”) AND (“fac-

attack")) OR (TITLE-
ABS-
KEY ("cardiac arrest"))) AND (LIMIT-
TO

tor*” OR “cause*” OR “reason*” OR “influence”) AND (“hospital*” OR

(PUBYEAR, 2020) OR LIMIT-
TO (PUBYEAR, 2019) OR LIMIT-
TO

“acute setting*”).

(PUBYEAR, 2018) OR LIMIT-
TO (PUBYEAR, 2017) OR LIMIT-
TO

APPENDIX 2
S T U DY S E L EC T I O N A N D P R I S M A F LOW D I AG R A M

Records idenfied through
database searching
(n = 13503)

Addional records idenfied
through manual searching,
including searching of systemac
review reference lists
(n = 12)

Records aer duplicates removed
(n = 9132)

Record tles screened
(n = 9132)

Records excluded based
on tle
(n = 8314)

Record abstracts screened
(n = 818)

Records excluded based
on abstract
(n = 497)

Full-text arcles assessed
for eligibility
(n = 321)

Full-text arcles excluded,
with reasons
(n = 297)

Studies included in
synthesis
(n = 24)

CABG paents (n= 38)
Primary diagnosis (n= 104)
Comorbidity data could not be
extracted for 30-day analysis (n= 80)
Grey literature (n= 7)
Review (n= 4)
No 30-day analysis (n= 62)
Non-adult sample (n= 1)
Not in English (n=1)
No 30-day analysis (n= 62)
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APPENDIX 3
M E T H O D O LO G I C A L Q UA L I T Y O F S T U D I E S
JBI critical appraisal checklist for cohort studies
Citation

Q1

Q2

Q3

Q4

Q5

Q6

Q7

Q8

Q9

Q10

Q11

Score/11

Atti et al. (2019)

Y

Y

Y

U

U

Y

Y

U

U

U

Y

6/11

Borzecki et al. (2016)

Y

Y

Y

U

U

Y

Y

Y

Y

Y

Y

9/11

Cheung et al.(2018)

Y

Y

Y

NA

NA

Y

Y

Y

Y

Y

Y

9/11

Dharmarajan et al. (2013)

Y

Y

Y

U

U

Y

Y

Y

Y

Y

Y

9/11

Dodson et al. (2019)

Y

Y

Y

U

U

Y

Y

Y

Y

Y

Y

9/11

Dreyer et al. (2015)

Y

Y

Y

Y

Y

Y

Y

Y

Y

Y

Y

11/11

Hess et al. (2016)

Y

Y

Y

N

N

Y

Y

Y

Y

Y

Y

9/11

Khera et al. (2017)

Y

Y

Y

U

U

Y

Y

Y

Y

Y

Y

9/11

Kociol et al. (2012)

Y

Y

Y

Y

Y

Y

Y

Y

Y

Y

Y

11/11

Li et al. (2019)

Y

Y

Y

U

U

Y

Y

Y

Y

Y

Y

9/11

Litovchik et al. (2019)

Y

Y

Y

U

U

Y

Y

Y

Y

Y

Y

9/11

Mahmoud & Elgendy (2018)

Y

Y

Y

NA

NA

Y

Y

Y

Y

Y

Y

9/11

McManus et al., (2016)

Y

Y

Y

NA

NA

Y

Y

Y

Y

Y

Y

9/11

McHugh & Ma (2013)

Y

Y

Y

NA

NA

Y

Y

Y

Y

Y

Y

9/11

Meadows et al. (2012)

Y

Y

Y

NA

NA

Y

Y

Y

Y

Y

Y

9/11

Nuti et al. (2016)

Y

Y

Y

Y

Y

Y

Y

NA

NA

NA

Y

10/13

Przybysz-Zdunek et al. (2012)

Y

Y

Y

NA

NA

Y

Y

Y

Y

Y

Y

9/11

Rodriguez et al. (2011)

Y

Y

Y

Y

Y

Y

Y

Y

Y

Y

Y

11/11

Southern et al. (2014)

Y

Y

Y

NA

NA

Y

Y

Y

Y

Y

Y

9/11

Tripathi et al. (2017)

Y

Y

Y

Y

Y

Y

Y

Y

Y

Y

Y

11/11

Tripathi et al. (2019)

Y

Y

Y

Y

Y

Y

Y

Y

Y

Y

Y

11/11

Zabawa et al. (2018)

Y

Y

Y

NA

NA

Y

Y

Y

Y

Y

Y

Abbreviation: Y, yes; N, no; U, unclear; NA; not applicable.

Questions:
1. Were the two groups similar and recruited from the same population?
2. Were the exposures measured similarly to assign people to both exposed and unexposed groups?
3. Was the exposure measured in a valid and reliable way?
4. Were confounding factors identified?
5. Were strategies to deal with confounding factors stated?
6. Were the groups/participants free of the outcome at the start of the study (orat the moment of exposure)?
7. Were the outcomes measured in a valid and reliable way?
8. Was the follow-up time reported and sufficient to be long enough for outcomes to occur?
9. Was follow-up complete, and if not, were the reasons to loss to follow-up described and explored?
10. Were strategies to address incomplete follow-up utilised?
11. Was appropriate statistical analysis used?
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JBI Citical Appraisal Checklist for Quasi-experimental studies
Citation

Q1

Q2

Q3

Q4

Q5

Q6

Q7

Q8

Q9

Score /9

Gasbarro et al. (2015)

Y

Y

U

Y

Y

Y

Y

Y

Y

8/9

Abbreviation: Y, yes; N, no; U, unclear; NA; not applicable.

Questions:
1. Is it clear in the study what is the ‘cause’ and what is the ‘effect’ (i.e. there is no confusion about which variable comes first)?
2. Were the participants included in any comparisons similar?
3. Were the participants included in any comparisons receiving similar treatment/care, other than the exposure or intervention of interest?
4. Was there a control group?
5. Were there multiple measurements of the outcome both pre and post the intervention/exposure?
6. Was follow-up complete and if not, were differences between groups in terms of their follow-up adequately described and analysed?
7. Were the outcomes of participants included in any comparisons measured in the same way?
8. Were outcomes measured in a reliable way?
9. Was appropriate statistical analysis used?
JBI Critical Appraisal Checklist for Randomised Controlled Trials studies
Citation

Q1

Q2

Q3

Q4

Q5

Q6

Q7

Q8

Q9

Q10

Q11

Q12

Q13

Score /13

Cajanding(2017)

Y

Y

Y

N

N

N

Y

Y

Y

Y

Y

Y

Y

10/13

Abbreviation: Y, yes; N, no; U, unclear; NA; not applicable.

1. Was true randomisation used for assignment of participants to treatment groups?
2. Was allocation to treatment groups concealed?
3. Were treatment groups similar at the baseline?
4. Were participants blind to treatment assignment?
5. Were outcomes assessors blind to treatment assignment?
6. Were outcomes assessors blind to treatment assignment?
7. Were treatment groups treated identically other than the intervention of interest?
8. Was follow-up complete and if not, were differences between groups in terms of their follow-up adequately described and analysed?
9. Were participants analysed in the groups to which they were randomised?
10. Were outcomes measured in the same way for treatment groups?
11. Was Were outcomes measured in a reliable way?
12. Was appropriate statistical analysis used?

UK

Cajanding
(2017)

RCT

Retrospective
cohort

USA

Borzecki et al.
(2016)

Retrospective

cohort

USA

Atti et al.

Study design

(2019)

Country

Study

AMI
Sample: 143
Age: 14.7% ≤40
28.7% 41–50 35.7% 51–
60 16.7% 61–70
4.9% ≥71
Sex (%Female): 37.1

Veteran's affair patients
with AMI.
Sample: 4986
Age: Not fully abstracted
data = 69.8,
fully abstracted
data = 70.8
Sex (%Female): Not
fully abstracted
data = 1.6, fully
abstracted data = 3.0

cariogenic shock.
Sample: 46435
Age: 52.6% ≤65.
Sex (%Female): 33.7%

AMI and PCI with

Participants
characteristics
& sample size

Intervention group
received usual
care plus the
intervention of
the structured
discharge
planning program.
This comprises
of a series of
personalised
lecture
discussions,
feedback,
collaborative
problem solving,
goal setting
and action
planning that was
conducted.
3 consecutive daily
sessions lasting
between 30 and
45 minutes.

NA

NA

Intervention
description

The effectiveness of a
nurse-led
structured discharge
planning program on
perceived functional
status, cardiac
self-efficacy, patient
satisfaction,
and unexpected hospital
revisits among
Filipino patients with
AMI.

processes of care
between Potentially
Preventable
Readmissions
software-flagged
and nonflagged cases.

30-day readmission
rate.
Secondary outcomes
were predictors of
readmission and cost
of care associated
with
the index hospitalisation.

Primary outcome was

Outcome measured

C H A R AC T E R I S T I C S O F I N C LU D E D S T U D I E S FO R M E T H O D O LO G I C A L R E V I E W

APPENDIX 4

Minnesota Living with Heart
Failure Questionnaire, Cardiac
self-efficacy questionnaire,
short-form patient satisfaction
questionnaire.
To determine the effectiveness of
a nurse-led
structured discharge planning
program on perceived
functional status, cardiac self-
efficacy, patient satisfaction,
and unexpected hospital revisits
among Filipino patients with
AMI.

2006 to 2010 national VA
administrative data.
To assess whether
the PPR algorithm identifies
preventable readmissions, we
compared processes of care
between PPR software-flagged
and nonflagged cases

Nationwide Readmission Database

Data source & objectives

Angina, hypertension, diabetes,
stroke, asthma or COPD,
peripheral vascular disease

Heart failure, valvular disease,
peripheral vascular disease,
diabetes, hypertension,
chronic pulmonary disease,
renal failure, metastatic
cancer, primary cancer,
depression, alcohol abuse,
CAD, hypertension,
hyperlipidaemia, smoking,
chronic kidney disease

MI, prior PCI, prior CABG,
prior stroke, AF, Ventricular
tachycardia/fibrillation,
Peripheral vascular disease,
Anaemia, Coagulopathy,
Chronic pulmonary disease,
Chronic kidney disease,
Neurological disorders/
paralysis

Hypertension, Diabetes, HF, prior

Comorbiditya/
Outcome(s) of Interest

(Continues)

Major bleeding,
vascular
complications,
stroke/TIA,
respiratory
complications,
sepsis, AKI
requiring
dialysis

Complications
during initial
admission
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USA

Dharmarajan
et al.

Dodson et al.
(2019)

USA

USA

Cheung et al.
(2018)

(2013)

Country

Study

APPENDIX 4 (Continued)

Prospective cohort

Retrospective
cohort

Retrospective
cohort

Study design

AMI.
Sample: 3006
Age: µ = 81.5
Sex (%Female):44.4

Age: 65–74 = 28.6%
75–8 4 = 40.9%
85 += 30.5%
Sex (%Female): 53.6%

AMI.
Sample: 108992

Catheter ablation
of myocardial
infarction-associated
ventricular
tachycardia.
Sample: 4000
Age: µ = 66.3
Sex (%Female): 11.3

Participants
characteristics
& sample size

NA

NA

NA

Intervention
description

The outcome was
all-c ause
readmission at 30 days.

occurring on each day (0–
30) after discharge;
(2) the most common
readmission diagnoses
occurring during
cumulative time
periods (days 0–3 ,
0–7, 0–15, and 0–3 0)
and consecutive time
periods (days 0–3 , 4–7,
8–15, and 16–3 0)
after hospitalisation;
(3) median time to
readmission for
common readmission
diagnoses; and (4) the
relationship between
patient demographic
characteristics and
readmission
diagnoses and timing.

(1) the percentage of 30-
day readmissions

In-hospital outcomes,
costs, and 30-day
readmissions after
catheter ablation
of myocardial
infarction–associated
VT.

Outcome measured

Patient Health Questionnaire to
assess depression, telephone
interview for cognitive status for
cognitive ability, Seattle Angina
questionnaire, SF−12 health
status measures, functional
assessment and review of
medical record to assess
presence of comorbid disease.
To develop
and validate an AMI readmission
risk model for older patients
that considered functional
impairments and was suitable for
use before hospital discharge.

To examine readmission diagnoses
and timing among Medicare
beneficiaries
readmitted within 30 days after
hospitalisation for heart
failure, acute myocardial
infarction, or
pneumonia.

2007–2009 Medicare fee-for-
service claims data.

Nationwide readmissions database.
To examine in-hospital outcomes,
costs, and 30-day
readmissions after catheter
ablation
of
myocardial
infarction–associated
VT.

Data source & objectives

Hypertension, Dyslipidaemia,
arrythmia, heart failure, prior
MI, prior revascularisation
procedure, peripheral artery
disease, valvular disease,
stroke, Diabetes, COPD,
smoking, disability, cognitive
impairment, depression

conduction disorders

HF, AMI, Renal disorder,
pneumonia, arrythmias and

HF, Prior PPM/ICD, PCI, CABG,
hypertension, diabetes,
hyperlipidaemia, obesity,
stroke, valvular heart disease,
peripheral vascular disease,
pulmonary hypertension,
chronic lung disease, renal
disease, cancer, anaemia,
coagulopathy, smoking,
alcohol abuse

Comorbiditya/
Outcome(s) of Interest

(Continues)

Complications
during initial
admission
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Country

USA

USA

Study

Dreyer et al.
(2015)

Gasbarro et al.
(2015)

APPENDIX 4 (Continued)

Quasi-experimental

Retrospective
cohort

Study design

AMI.
Sample: 50
Age: µ = 62.0
Sex (%Female): 34.0

AMI.
Sample: 4775
Age: 18–65
Sex (%Female): 36.4

Participants
characteristics
& sample size

Clinical pharmacist
intervention
encompassing
education (using
the teach back
method) and
counselling
addressing names
of medications,
indications,
dosages,
adverse effects,
medication
adherence,
encouragement
of exercise,
alcohol and
smoking
advice and
cost concerns.
This education
occurred
once prior to
discharge, with
a follow-up
phone call within
48 hours of
discharge.

NA

Intervention
description
Healthcare Cost and Utilisation
Project State Inpatient
Dataset.
Examined sex differences in the
rate, timing, and principal
diagnoses of 30-day
readmissions, including
the independent effect of sex
following adjustment for
confounders

Medical chart reviews and patient
interviews.
To evaluate the overall effect
of clinical pharmacist
interventions on
preventing hospital readmissions
and improving the health of
patients with AMI. Secondary
objectives include identifying
trends in the demographic
characteristics of AMI patients,
identifying potential barriers to
adherence, and assessing the
average time spent by a pharmacist
counselling AMI patients

The primary outcome
was the
all-c ause 30-day
readmission rate for
AMI patients

Data source & objectives

Sex differences in the
rate, timing, and
principal diagnoses of
30-day readmissions,
including
the independent effect
of sex following
adjustment for
confounders.

Outcome measured

Obesity associated with
the following factors:
polypharmacy/medication
adherence, passed teach
back counselling, cardiac
readmissions including stent
thrombosis, atherosclerosis
and diastolic heart failure.

HF, AMI, UA and other acute
ischaemic HD, Chronic
angina and CAD, valvular
heart disease, congenital/
hypertensive disease,
arrythmias and conduction
disorders, syncope, stroke/
TIA, pulmonary embolism,
peripheral vascular disease,
pneumothorax, cardio-
respiratory failure, COPD,
pneumonia, sepsis, UTI,
cellulitis, CD infection,
renal failure, anaemia,
gastrointestinal haemorrhage,
diabetes, lung fibrosis/other
conditions, hip fracture, other
lung disorders, cancer (all
stratified by men and women)

Comorbiditya/
Outcome(s) of Interest

(Continues)

Complications
during initial
admission
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Country

USA

USA

Study

Hess et al.
(2016)

Khera et al.
(2017)

APPENDIX 4 (Continued)

Retrospective
cohort

Prospective cohort
study

Study design

AMI.
Sample: 212171
Age: µ = 66.9
Sex (%Female): 37.9

AMI with PCI treatment.
Sample: 12312, Not
readmitted = 10,986,
Readmitted = 1326
Age: Not Readmitted
Mdn = 59.0,
Readmitted Mdn = 61.5
Sex (%Female): Not
Readmitted
Mdn = 27.6
Readmitted Mdn = 31.8

Participants
characteristics
& sample size

NA

NA

Intervention
description

Monthly risk-adjusted
rates of in-hospital
and 30-day
Post-discharge mortality.

Our primary outcome
was unplanned
rehospitalisations
(inpatient or
observation status)
within 30
days after discharge.

Outcome measured

National readmission database.
To evaluate whether the
announcement or the
implementation of HRRP was
associated
with an increase in either
in-hospital or 30-day post-
discharge mortality following
hospitalisation for
AMI, HF, or pneumonia.

Hospital medical and billing data as
well as participant phone call
confirmation of readmission.
To examine rates of unplanned
rehospitalisations
among patients of all ages
within 30 days of the index
hospitalisation for acute MI,
to assess
hospital-level
variation in 30-day unplanned
rehospitalisations, and to
identify
Factors associated with 30-day
unplanned
Rehospitalisations.

Data source & objectives

electrolyte disorder, sepsis,
solid malignancy, leukaemia/
metastatic malignancy,
anaemia, chronic skin
ulcer, delirium/dementia,
malnutrition, previous MI
or PCI or CABG, chest
pain, sepsis, dysrhythmias,
renal failure, myocarditis,
hypertension, gastrointestinal
haemorrhage, cerebrovascular
disease

Age, heart failure, chronic
atherosclerosis, cardiac
arrythmia, valvular disease,
stroke/TIA, cerebrovascular
disease, paralysis, peripheral
vascular disease, diabetes,
AKI, end-s tage renal disease/
haemodialysis, chronic
kidney disease, COPD,
pneumonia, asthma, fluid/

BMI, smoking, hypertension,
dyslipidaemia, cerebrovascular
disease, stroke/TIA, AF,
Peripheral artery disease,
chronic lung disease, diabetes,
previous MI or PCI or CABG,
previous HF, GI bleeding,
dialysis

Comorbiditya/
Outcome(s) of Interest

(Continues)

Complications
of devices/
implant,
complication
from surgery or
medical care

MI, HF, cardiogenic
shock

Complications
during initial
admission
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Country

USA/
Canada

China

Israel

USA

Study

Kociol et al.
(2012)

Li et al. (2019)

Litovchik et al.
(2019)

Mahmoud
(2018)

APPENDIX 4 (Continued)

Retrospective
cohort

Prospective cohort
study

Prospective cohort
study

Retrospective
cohort

Study design

AMI with cardiogenic
shock.
Sample: 39807
Age: µ = 66.5
Sex (%Female): 33.2

NA

NA

NA

AMI.
Sample: 3387
Age: Mdn = 61
Sex (%Female): 23.1

ACS.
Sample: 13010
Age: µ = 63.0
Sex (%Female): 23.0

NA

Intervention
description

STEMI with PCI.
Sample: 5745
Age: µ = 61
Sex (%Female):22.6

Participants
characteristics
& sample size

The primary outcome
of interest was
30-day all-c ause
readmission.

National readmission database.
To compare
30-day readmissions in women
versus men initially admitted
with AMI complicated with
cardiogenic shock.

Hospital records, follow-up visits
and a telephone call at 30 days.
To explore the prognosis of
readmitted
patients, and analysed national
trends in readmission rates
following ACS over the past
decade.

hospitalisation
for AMI, characterised readmission
timing and diagnoses, and
identified
predictors of both unplanned
all cause and unplanned
cardiovascular
readmissions

rehospitalisation
to an acute care hospital
within 30 days from
the date of discharge.
Death events by death
certificate or record
in death cause
registration system.
incidence and outcomes
of patients
readmitted after an
acute
coronary syndrome

Chart abstraction, patient
interviews and central
laboratory analysis.
To calculate rates of unplanned
readmissions after

Hospital data and case report
forms.
To determine international
variation in and predictors of
30-day readmission
rates after STEMI and country-level
care patterns.

Data source & objectives

Our primary outcome
was the 30-day
unplanned all-c ause
readmission, defined as
the first unplanned

Predictors of 30-day
post-discharge
all-c ause and
nonelective
readmissions.

Outcome measured

disturbance, metastatic
cancer, neurological disorders,
obesity, paralysis, peripheral
vascular disease, psychosis
pulmonary circulatory
disorder, chronic renal failure,
peptic ulcer disease, valvular
heart disease, weight loss

prior MI, Prior PCI, prior CABG,
stroke, CAD, smoking,
dyslipidaemia, AIDS,
anaemia, rheumatologic
disease, chronic blood loss,
CHF, COPD, coagulopathy,
depression, diabetes,
drug abuse, hypertension,
hypothyroidism, chronic
liver disease, lymphoma,
fluid and electrolyte

Smoking, family hx of CAD,
dyslipidaemia, hypertension,
diabetes, chronic renal failure,
COPD, peripheral vascular
disease, stroke/TIA, past
MI, congestive HF, unstable
angina

dysfunction and prior HF

MI, single-vessel disease, multiple
vessel disease, prior MI or
PCI, hypertension, diabetes,
dyslipidaemia, smoking, prior
stroke, prior chronic renal

hypertension, CAD, COPD, AF,
multivessel disease, chronic
inflammatory condition,
recurrent ischaemia, prior
CABG, HF, chronic liver
disease, dialysis, diabetes,
smoking

Comorbiditya/
Outcome(s) of Interest

|
(Continues)

Acute renal failure,
pneumonia,
gastrointestinal
bleeding,
intracranial
haemorrhage,
stroke/
TIA, Sepsis,
deep vein
thrombosis/
pulmonary
embolism, AF,
ventricular
tachycardia, VF

stroke, bleeding

AF, recurrent
angina,
recurrent AMI,
tachycardia,
HF, infection,
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USA

McManus

Meadows
et al.
(2012)

USA

USA

McHugh et al.
(2013)

et al.
(2016)

Country

Study

APPENDIX 4 (Continued)

Retrospective
cohort

Prospective cohort

Retrospective
cohort

Study design

ACS with PCI.
Sample: 6687
Age: µ = 56.5
Sex (%Female): 22.6

Sample: 2187
Age: µ = 73.0
Sex (%Female): 38.0

ACS.

AMI.
Sample: 62394
Age: Mdn = 78.0
Sex (%Female): 49.0

Participants
characteristics
& sample size

NA

NA

NA

Intervention
description

Readmission within
30 days

study outcome was
whether the patient
had an unscheduled
readmission at any
of our 6
participating hospitals for
any reason during the
following 30 days.

Our primary

30-day readmission.
Risk adjustment

Outcome measured

US administrative claims data. The
objective of this study was to
characterise the
rehospitalisation of patients with
acute coronary syndrome
receiving percutaneous
coronary intervention in the
U.S. health benefit plan.

participants in computer-
assisted face-to-f ace
interviews or by phone within
72 hours of discharge.
The Telephone Interview for
Cognitive Status (TICS) was
used to assess cognitive
status, the Patient Health
Questionnaire was used
to assess depression, the
generalised anxiety disorder
questionnaire was used for
assessing anxiety. A 4-item
version of the Perceived Stress
Scale was used to assess
stress. To assess participants’
engagement with health care
the Patient Activation Measure
(PAM6) was used.
To compare the performance of a
CMS-like model to
each of 3 models that incorporated
a number of variables
representing clinical,
psychosocial,
and socio-demographic
characteristics, respectively

Data were collected from

Linked data.
To determine the relationship
between hospital nursing; i.e.
nurse work
environment, nurse staffing levels,
and nurse education, and
30-day readmissions among
Medicare
patients with heart failure, acute
myocardial infarction, and
pneumonia.

Data source & objectives

heart failure, stroke, other
cardiovascular conditions

valvular heart disease, TIA/
stroke, peripheral vascular
disease, diabetes,
Chronic kidney disease, dialysis,
chronic lung disease, anaemia,
Alzheimer's disease, cancer,
hypertension, depression,
anxiety, stress, cognitively
impaired, anterior myocardial
infarction, smoking, heavy
alcohol consumption

PCI, CABG, CAD/MI, HF, AF,

HF, coronary atherosclerosis,
AMI, cardiac dysrhythmias,
nonspecific chest pain,
pneumonia, renal failure,
respiratory failure,
gastrointestinal haemorrhage

Comorbiditya/
Outcome(s) of Interest

(Continues)

cardiogenic
shock

HF, cardiac arrest,
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Country

USA

Poland

Canada

Study

Nuti et al.
(2016)

Przybysz-
Zdunek
et al.
(2012)

Southern et al.
(2014)

APPENDIX 4 (Continued)

Retrospective
cohort

Retrospective
cohort

Retrospective
cohort

Study design

ACS.
Sample: 3411
Age: µ = 65.6
Sex (%Female): 30.9

PCI with admission
related to ICD−9-CM
code.
Sample: 2039
Age: µ = 65.7
Sex (%Female): 31.8

VA and non-VA AMI.
Sample: 140205
Age: VA µ = 75.5, not VA
µ = 77.5
Sex (%Female): 0.0

Participants
characteristics
& sample size

NA

NA

NA

Intervention
description

Primary outcomes
were inpatient
and emergency
department–only
readmissions, at
30 days.

Readmission within
30 days

30-day risk-s tandardised
mortality rates
and risk-s tandardised
readmission rates
for VA and non-VA
hospitals. Mean-
aggregated within
MSA
differences in mortality
and readmission
rates were also
assessed.

Outcome measured

APPROACH database.
To profile the timing, main
diagnoses and survival
outcomes of inpatient and
emergency department
readmissions after acute
coronary syndrome (ACS).

National Health Fund registry.
The aim of this study was to
assess rehospitalisation and
repeat revascularisation
within 30 days of the initial
hospitalisation for PCI, using
data from Opolskie Voivodeship,
National Health Fund (NHF)
Registry.

CMS standard analytics files and
enrolment database as well as
VA administrative claims.
Objective—To assess and compare
mortality and readmission
rates among men in VA and
non-VA hospitals.
To avoid confounding geographic
effects with health care
system effects.

Data source & objectives

HF, diabetes, cancer, liver
disease, renal disease,
pulmonary disease, peripheral
vascular disease, dementia,
cerebrovascular disease,
peptic ulcer disease, rheumatic
disease, paraplegia, HIV, MI,
renal disease, heart failure

diabetes, congestive heart
failure, chronic renal
insufficiency, hypertension,
peripheral artery disease,
bradyarrhythmia, atrial
fibrillation, cardiac arrest

VA hospital, prior PCI or
CABG or HF or MI or
ACS or atherosclerosis or
cardiopulmonary respiratory
failure/shock, valvular
disease, arrythmia, heart
disease, hypertension, stroke,
cerebrovascular disease, renal
failure, COPD, pneumonia,
diabetes, dementia,
malnutrition, functional
disability, peripheral
vascular disease, metastatic
cancer, psychiatric disorder,
chronic liver disease, severe
hematologic disorders, iron
deficiency, depression, seizure
disorder, fibrosis of lung or
chronic lung disorder, asthma,
end-s tage renal disease,
nephritis, urinary tract
disorder, UTI, pneumothorax,
other lung disorders, fluid/
electrolyte disorders,
psychiatric disorders, drug/
alcohol abuse, peptic ulcer, GI
tract disorders, Parkinson's/
Huntington's disease,
vertebral fractures, sepsis

Comorbiditya/
Outcome(s) of Interest

(Continues)
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Country

USA

USA

France

Study

Tripathi et al.
(2017)

Tripathi et al.
(2019)

Zabawa et al.
(2018)

APPENDIX 4 (Continued)

Retrospective
cohort

Retrospective
cohort

Retrospective
cohort

Study design

AMI.
Sample: 624
Age: Readmitted µ = 79.2;
Non-readmitted
µ = 78.1
Sex (%Female):
Readmitted
patients = 56.9;
non-readmitted
patients = 57.1

PCI in STEMI patients.
Sample: 22257
Age: µ = 62.3
Sex (%Female): 26.0

PCI with inpatient
admission related to
ICD−9-CM code.
Sample: 206869
Age: µ = 65.0
Sex (%Female): 32.2

Participants
characteristics
& sample size

NA

NA

NA

Intervention
description

The primary outcome was
the first all-c ause 30-
day rehospitalisation
in an acute care
hospital, in the same
or another
hospital.

ICD−9 codes in
primary diagnosis
filed during readmission
observation. We
identified 445
different ICD−9-CM
diagnosis codes and
combined the
ones with similar
diagnoses to
form clinically important
groups.

The primary outcome
was the 30-day
readmission rate in
the cohort and
secondary outcomes
were factors
associated with
readmission. Causes
of readmission were
identified using

30-day readmission and
readmission
costs

Outcome measured

Linked data.
To investigate the association
between
Post-discharge ambulatory care
and 30-day rehospitalisation
after discharge of elderly patients
hospitalised for AMI, after
adjusting for these factors.

National readmission database.
To explore pattern, causes and
factors associated with 30-day
readmission
after multivessel PCI in STEMI
patients.

National readmission database.
The objectives of this study were
to evaluate the rate
of post-P CI 30-day readmission
and the associated costs in a
cohort of patients who had
inpatient PCI. In addition, we
examined the factors associated
with the risk of 30-day
readmissions and higher
costs after accounting for all
insurance types, geographical
variations, and
individual- and
hospital-level
factor

Data source & objectives

diabetes, congestive heart
failure, acute kidney failure,
chronic kidney failure, atrial
fibrillation, coronary heart
disease

drug abuse

obesity, coagulopathy,
chronic kidney disease,
hypothyroidism, hypertension,
diabetes, congestive heart
failure, chronic pulmonary
disease, peripheral vascular
disease, anaemia, neurological
disorder including paralysis,
rheumatological disorder,
psychiatric disorder including

ischaemic heart disease, heart
failure, peripheral artery
disease, chronic pulmonary
disease, diabetes, renal failure

Comorbiditya/
Outcome(s) of Interest
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